Tuesday , 23 July 2019
Home / Business / CannTrust suspends sales of cannabis products during Canada regulatory review

CannTrust suspends sales of cannabis products during Canada regulatory review

FILE PHOTO: Marijuana plants are displayed for sale at Canna Pi medical marijuana dispensary in Seattle, Washington, November 27, 2012. REUTERS/Anthony Bolante/File Photo TORONTO (Reuters) – Canada-based medical cannabis company CannTrust Holdings Inc said on Thursday it suspended sales of cannabis products after the federal health regulator found the company sold marijuana produced in unlicensed …

Continue reading article

About Reuters

Since 1850, we have experimented, invented, and created content and news solutions to become the world’s leading international news agency. Always at the forefront of real-time breaking news and high-impact global multimedia content, we are constantly innovating our products and services to meet your business needs. Whether we are serving broadcasters, publishers, brands, agencies, or direct to consumers, Reuters provides award-winning coverage of the day’s most important topics, including: business, finance, politics, sports, entertainment, technology, health, environment, and much more.